LETROJUST 2.5 MG – 5 TABLETS
LETROJUST 2.5 MG is an aromatase inhibitor specifically formulated for the treatment of hormone receptor-positive breast cancer in postmenopausal women. By reducing estrogen levels, it helps control the growth of cancerous cells.
Due to the US administration recent actions on postal shipments we have had to halt Card payment for USA, you can still use Echeck for USA. AUS, UK and other countries can still use card payment. We hope to allow card payments back to USA customers shortly. If you have any questions, please email us at order@aipctshop.info
From wars to politics to daily life — we’ve lost our way. It’s time to return to common sense.
15% off on all product *minimum spend 35$USD, use code : COMMONSENSE15 starts from 16th – 25th September 2025
Description
LETROJUST 2.5 MG works by inhibiting the aromatase enzyme, which is responsible for converting androgens to estrogens. This reduction in estrogen is critical for managing hormone-sensitive breast tumors, making LETROJUST an essential option in breast cancer therapy.
Usage Instructions
Dosage: Follow your healthcare provider’s instructions regarding dosage.
Administration: Take the tablet whole with water; do not chew or crush.
Timing: Typically taken once daily at the same time to ensure consistency.
Missed Dose: If you miss a dose, take it as soon as you remember. If it’s close to your next dose, skip the missed dose. Do not double the dose.
Medicinal Advantages
Targeted Treatment: Specifically effective for hormone receptor-positive breast cancer.
Estrogen Control: Significantly lowers estrogen levels, inhibiting tumor growth.
Postmenopausal Focus: Tailored for postmenopausal women for optimal efficacy.
Mechanism of Action
LETROJUST 2.5 MG inhibits the aromatase enzyme, leading to decreased estrogen production in the body. This is vital for preventing the proliferation of hormone-sensitive breast cancer cells.
Off-Label Uses
Consult your healthcare provider for any potential off-label uses based on your specific health needs.
Expert Advice
Always adhere to your healthcare provider’s instructions regarding dosage and treatment duration. Regular monitoring is crucial for assessing the treatment’s effectiveness.
Precautions
Allergic Reactions: Inform your doctor of any allergies, especially to aromatase inhibitors.
Pregnancy/Breastfeeding: Not recommended during pregnancy or breastfeeding.
Bone Health: Monitor for changes in bone density; discuss preventive measures with your healthcare provider.
Storage Conditions
Store LETROJUST 2.5 MG in a cool, dry place away from direct sunlight. Keep it out of reach of children and regularly check the expiration date.
FAQs
Q: What condition does LETROJUST 2.5 MG treat?
A: It is primarily used for the treatment of hormone receptor-positive breast cancer.
Q: How should I take LETROJUST 2.5 MG?
A: Take it once daily with water, following your healthcare provider’s guidance.
Q: Can I stop taking LETROJUST 2.5 MG if I feel better?
A: Consult your healthcare provider before discontinuing any medication.
Q: Are there interactions with other medications?
A: Yes, inform your doctor of all medications you are taking to prevent potential interactions.
Q: How often should I have follow-up appointments?
A: Regular follow-ups are important; consult your provider for specific guidance.
Additional information
| Weight | 10 g |
|---|---|
| Dosage Type | tablet |
Related products
Recently viewed
Subtotal: USD $73.60